HbA1c is a widely used measure of long-term glucose control in diabetes management. Clinical guidelines typically recommend maintaining HbA1c below 7% for adults with type 2 diabetes to reduce the risk of complications, including cardiovascular events.1
To better understand the relationship between specific HbA1c values and cardiovascular event risk in diabetics, we studied 852,243 patients with type 2 diabetes and no prior history of stroke or MI. Time-weighted average HbA1c levels were tracked for three years starting at least one year post-diagnosis and monitored for evidence of new stroke or MI. We accounted for patient demographics, smoking status, BMI classifications, social vulnerability, and comorbidities in our analysis.
We found that the likelihood of MI rose progressively at higher average HbA1c levels, particularly above 7.0%, as seen in Figure 1. Patients with an average HbA1c between 7.0 and 7.4% were 13% more likely to experience an MI, and those with an average HbA1c of 10.0% or higher were 153% more likely, compared to patients with an average HbA1c between 6.75 and 6.99%. Notably, average HbA1c levels below 5.4% did not confer any additional benefit, with MI risk similar to or higher than for those with an average HbA1c between 6.75 and 6.99%.
The pattern for stroke was similar but less steep, with a significant rise beginning at average HbA1c levels above 7.0%. Patients are 140% more likely to have a stroke if their average HbA1c was 10.0% or higher compared to patients with an average HbA1c between 6.75 and 6.99%. The likelihood of stroke was 5% lower among patients with an average HbA1c between 6.1 and 6.4%, while the likelihood was 7% lower for those with an average HbA1c between 5.7 and 6.0%. Notably, average HbA1c levels below 5.7% did not confer any additional benefit, with stroke risk similar to or higher than for those with an average HbA1c between 6.75 and 6.99%.